Skip to content

A clinical study of the effects of high-energy nutritional support on body composition and neurological function in patients with ALS

A clinical study of the effects of high-energy nutritional support on body composition and neurological function in patients with ALS

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117316
Enrollment
Unknown
Registered
2026-01-22
Start date
2025-06-28
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amyotrophic Lateral Sclerosis

Interventions

ALS patient group:Add high-energy nutritional supplementation (Fresubin 53.8 g/day, providing approximately 970 kcal, 8.6 g protein, and 7.6 g fat) to standard diet (energy: 25–30 kcal/kg/day, protein

Sponsors

China Rehabilitation Research Center (Beijing Bo'ai Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Confirmed diagnosis of ALS. 2. Aged between 18 and 75 years (inclusive). 3. Normal digestive function and tolerance to enteral nutrition. 4. Willing and able to comply with medical instructions and complete the treatment protocol.

Exclusion criteria

Exclusion criteria: 1. History of gastrointestinal surgery that impairs digestive or absorptive function. 2. Portal hypertension due to esophageal or gastric varices. 3. Concurrent other diseases that may affect body composition.

Design outcomes

Primary

MeasureTime frame
Muscle mass, body fat percentage, and ALS FRS-R score;

Secondary

MeasureTime frame
NRS2002 nutritional screening score, GLIM malnutrition assessment score, GUSS score, expiratory/inspiratory score;

Countries

China

Contacts

Public ContactLu Haitao

China Rehabilitation Research Center (Beijing Bo'ai Hospital)

13051760807@163.com+86 198 5811 7602

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026